English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

S olid organ transplant (SOT) procedures are used to treat patients with endstage diseases of the kidney, liver, heart, or lungs.1 After an SOT procedure, patients must take immunosuppressant drugs to prevent organ rejection. Medications frequently used include calcineurin inhibitors like Tacrolimus, glucocorticoids like prednisone, and antiproliferative agents such as mycophenolic acid. These medications can lead to increased bone loss and osteoporosis in the SOT population that ultimately correspond with a higher risk of sustaining a fragility fracture.1,2 Current literature is devoid of papers addressing the outcomes of emergent/urgent lowerextremity fracture surgery in the SOT population. Research into elective orthopedic procedures suggested that adult SOT patients had more complications and infections postoperatively than did nonSOT patients.3,4 A study of nonSOT patients 65 years and older found the 90day mortality of intertrochanteric hip fracture patients to be 15%.5 To better guide treatment in SOT fracture patients, we aim to assess the 90day medical and surgical complication rates and 1year mortality rates of SOT patients who undergo emergent lowerextremity fracture repair surgery.

Solid Organ Transplant Patients Suffer From Multiple Complications After Sustaining an Emergent Fracture of the Lower Extremities